Liu, Bin https://orcid.org/0000-0003-1736-9392
Nguyen, Hung V.-T. https://orcid.org/0000-0002-6945-4057
Jiang, Yivan
Wang, Aiden X. https://orcid.org/0000-0001-6335-9836
Lensch, Valerie https://orcid.org/0000-0003-0371-2866
Sun, Zehao https://orcid.org/0000-0002-9720-694X
Boyer, Zane H.
Raftopoulos, Philip A.
Dai, Yutong https://orcid.org/0009-0009-1188-4124
MacNicol, Piper L.
Wang, Yuyan
Jyotsana, Nidhi
Wang, Wencong
Bhagchandani, Sachin
Hemdev, Sanjana https://orcid.org/0000-0002-6505-1023
Shieh, Peyton
Kristufek, Samantha L.
Boucher, Magalie https://orcid.org/0009-0008-6293-6775
Downes, Michael
Evans, Ronald M. https://orcid.org/0000-0002-9986-5965
MacMillan, David W. C. https://orcid.org/0000-0001-6447-0587
Johnson, Jeremiah A. https://orcid.org/0000-0001-9157-6491
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (2R01CA220468-06A1, 2R01CA220468-06A1)
Article History
Received: 12 November 2024
Accepted: 10 July 2025
First Online: 9 September 2025
Competing interests
: J.A.J., H.V.-T.N. and Y.J. are shareholders of Window Therapeutics. D.W.C.M. declares an ownership interest in Dexterity Pharma, which has commercialized materials used in this work. The remaining authors declare no competing interests.